Cargando…

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure

Detalles Bibliográficos
Autores principales:	Malgie, Jishnu, Brugts, Jasper J., de Boer, Rudolf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504451/ https://www.ncbi.nlm.nih.gov/pubmed/37715465 http://dx.doi.org/10.1002/ctm2.1372

Ejemplares similares

Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy
por: Malgie, Jishnu, et al.
Publicado: (2023)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Use of loop diuretics in patients with chronic heart failure: an observational overview
por: Scholte, Niels TB, et al.
Publicado: (2023)

Pitfalls in haemodynamic monitoring based on the arterial pressure waveform
por: Camporota, Luigi, et al.
Publicado: (2010)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

The real-life heart failure patient: importance of guideline-directed medical therapy
por: van Hout, G. P. J., et al.
Publicado: (2021)

Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm
por: Kenig, Ariel, et al.
Publicado: (2021)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Remote Monitoring in Chronic Heart Failure Patients: Is Non-Invasive Remote Monitoring the Way to Go?
por: Veenis, Jesse F., et al.
Publicado: (2021)

Haemodynamic monitoring in acute heart failure – what you need to know
por: Jasińska-Gniadzik, Karolina, et al.
Publicado: (2022)

Perioperative goal directed haemodynamic therapy – do it, bin it, or finally investigate it properly?
por: Drage, Stephen, et al.
Publicado: (2007)

Highs and lows in high-risk surgery: the controversy of goal-directed haemodynamic management
por: Takala, Jukka
Publicado: (2005)

Modulating gut microbial metabolism in heart failure: Opportunities and challenges
por: Tang, W. H. Wilson, et al.
Publicado: (2021)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies
por: Malgie, Jishnu, et al.
Publicado: (2020)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Combined aquaretic and diuretic therapy in acute heart failure
por: Goyfman, Michael, et al.
Publicado: (2017)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

Diuretics in the management of chronic heart failure: when and how
por: Magdy, Joseph S, et al.
Publicado: (2022)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
por: Pethő, Ákos Géza, et al.
Publicado: (2023)

Haemodynamic optimisation: are we dynamic enough?
por: Parker, Sophie J, et al.
Publicado: (2011)

Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials
por: Clephas, Pascal R D, et al.
Publicado: (2023)

Clinical Update of the Latest Evidence for CardioMEMS Pulmonary Artery Pressure Monitoring in Patients with Chronic Heart Failure: A Promising System for Remote Heart Failure Care
por: Brugts, Jasper J., et al.
Publicado: (2021)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Haemodynamic determinants of quality of life in chronic heart failure
por: Fatrin, Serlie, et al.
Publicado: (2022)

Recent Advances in Remote Pulmonary Artery Pressure Monitoring for Patients with Chronic Heart Failure: Current Evidence and Future Perspectives
por: Clephas, Pascal R. D., et al.
Publicado: (2023)

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome
por: Qavi, Ahmed Hassaan, et al.
Publicado: (2015)

Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
por: Kim, Soo-Jin, et al.
Publicado: (2022)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
por: Chatur, Safia, et al.
Publicado: (2023)

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Jackson, Alice M., et al.
Publicado: (2020)

Invasive Devices and Sensors for Remote Care of Heart Failure Patients
por: Radhoe, Sumant P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l4a542kkvdrvj3tl7uv0i42snp